Product Information
METOPROLOL TARTRATE 37.5 MG TB is a generic product labeled by Advagen Pharma Ltd., priced at $0.0756 per EA under NDC 72888010101. Its NADAC has been published 123 times since Feb 21, 2024.
Strength
37.5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888010101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200981On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL TARTRATE 37.5 MG TB has been published 123 times since Feb 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0756 per EA |
|---|---|
| All-time high | $0.0809 (Apr 10, 2024) |
| All-time low | $0.0581 (May 22, 2024) |
| 52-week high | $0.0773 |
| 52-week low | $0.0730 |
| Median price | $0.0757 |
| Average price | $0.0741 |
| Largest weekly change | -19.6% (May 22, 2024) |
| Weeks tracked | 123 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the METOPROLOL TARTRATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of METOPROLOL TARTRATE 37.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL TARTRATE 37.5 MG TB, manufactured by Advagen Pharma Ltd., is $0.0756 per EA (NDC 72888010101), effective Jun 24, 2026.
How has the price of METOPROLOL TARTRATE 37.5 MG TB changed over time?
Over the history we have for it, the NADAC for METOPROLOL TARTRATE 37.5 MG TB has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for METOPROLOL TARTRATE 37.5 MG TB?
Since Feb 21, 2024, the NADAC for METOPROLOL TARTRATE 37.5 MG TB has ranged from a low of $0.0581 (May 22, 2024) to a high of $0.0809 (Apr 10, 2024), with a median of $0.0757 per EA.
Are there cheaper alternatives to METOPROLOL TARTRATE 37.5 MG TB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of METOPROLOL TARTRATE 37.5 MG TB, so no direct lower-cost alternative is listed.
Who manufactures METOPROLOL TARTRATE 37.5 MG TB?
METOPROLOL TARTRATE 37.5 MG TB (NDC 72888010101) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification